|
gene symbol | Description | Fold change | Adj p | Ranking among the upregulated genes | qRT-PCR |
Fold change mean (95% CI) | P value |
|
SAA1 | Serum amyloid A1 | 34.53 | <1.0 | 1 | 32.5 (11.5–53.5) | 0.003 |
NOS2 | Nitric oxide synthase 2, inducible | 20.11 | | 2 | | |
MMP13 | Matrix metallopeptidase 13 | 10.41 | | 5 | 7.8 (4.3–11.3) | 0.001 |
SOD2 | Superoxide dismutase 2, mitochondrial | 7.06 | | 15 | | |
TLR2 | Toll-like receptor 2 | 4.99 | | 25 | | |
MMP1 | Matrix metallopeptidase 1 | 3.50 | | 38 | 4.2 (0.2–8.2) | 0.03 |
MMP3 | Matrix metallopeptidase 3 | 2.28 | | 87 | 7.5 (3.2–11.7) | 0.003 |
PPARG | Peroxisome proliferator-activated receptor gamma | 1.65 | | 275 | | |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 1.55 | | 338 | | |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 1.53 | | 345 | | |
IL6 | Interleukin 6 (interferon, beta 2) | 1.47 | | 386 | 20.2 (–48.2) | 0.04 |
|
SOX9 | SRY (sex determining region Y)-box 9 | | | 370 | −(1.2–1.8) | 0.001 |
SOX5 | SRY (sex determining region Y)-box 5 | | | 143 | −(1.2–5.5) | 0.01 |
ACAN | Aggrecan | | | 104 | −(1.7–3.2) | 0.00006 |
COL9A1 | Collagen, type IX, alpha 1 | | | 84 | | |
NKX3-2 | NK3 homeobox 2 | | | 66 | −2.2 −(1.7–3.0) | 0.00004 |
FGFR3 | Fibroblast growth factor receptor 3 | | | 53 | | |
S100A1 | S100 calcium binding protein A1 | | | 41 | | |
PRG4 | Proteoglycan 4 | | | 29 | | |
LECT1 | Leukocyte cell derived chemotaxin 1 | | | 26 | −(1.6–18.5) | 0.001 |
COL11A1 | Collagen, type XI, alpha 1 | | | 25 | | |
COL11A2 | Collagen, type XI, alpha 2 | | | 20 | | |
FRZB | Frizzled-related protein | | | 14 | | |
COMP | Cartilage oligomeric matrix protein | | | 11 | −(3.2–9.2) | 0.00001 |
COL9A2 | Collagen, type IX, alpha 2 | | | 7 | | |
COL9A3 | Collagen, type IX, alpha 3 | | | 8 | | |
CHAD | Chondroadherin | | | 4 | | |
COL2A1 | Collagen, type II, alpha 1 | | | 3 | −(3.8–41.4) | 0.00001 |
|